4.5 Article

Identification of -Mangostin as an Agonist of Human STING

Journal

CHEMMEDCHEM
Volume 13, Issue 19, Pages 2057-2064

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201800481

Keywords

macrophage repolarization; STING; tumor microenvironment; typeI interferon; -mangostin

Funding

  1. National Natural Science Foundation of China (NSFC) [21521003, 81373326, 21290183, 81400826]
  2. Shenzhen Science and Technology Innovation Program [JCYJ20150529095420031, JCYJ20170412150827191, JCYJ20170818090609800]
  3. program of the Science and Technology Committee of Guangdong [2014A030312004, 2015A030313887]
  4. Adlai Nortye Biopharma Co., Ltd.

Ask authors/readers for more resources

The xanthone derivate 5,6-dimethylxanthenone-4-acetic acid (DMXAA, also known as ASA404 or vadimezan) is a potent agonist of murine STING (stimulator of interferon genes), but cannot activate human STING. Herein we report that -mangostin, which bears the xanthone skeleton, is an agonist of human STING, but activates murine STING to a lesser extent. Biochemical and cell-based assays indicate that -mangostin binds to and activates human STING, leading to activation of the downstream interferon regulatory factor (IRF) pathway and production of typeI interferons. Furthermore, our studies show that -mangostin has the potential to repolarize human monocyte-derived M2 macrophages to the M1 phenotype. The agonist effect of -mangostin in the STING pathway might account for its antitumor and antiviral activities.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available